Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Ala-D-Ala terminus is a short dipeptide at the end of peptidoglycan precursor pentapeptides in most bacterial species, especially Gram-positive. This motif is generated in the cytoplasm by D-Ala-D-Ala ligase and incorporated in lipid II, which is then used for cell wall assembly by transglycosylases and transpeptidases. Vancomycin and related glycopeptides specifically recognize and bind this motif by hydrogen bonding, blocking cell wall cross-linking and resulting in bacterial death. Many bacteria have evolved resistance mechanisms by substituting D-Ala-D-Ala with D-Ala-D-Lac or D-Ala-D-Ser, greatly reducing glycopeptide binding. As a non-protein, non-enzyme motif, the D-Ala-D-Ala terminus is best classified as a chemical target structure involved in bacterial cell wall assembly, not a classical receptor or enzyme. Its direct involvement in antibiotic resistance makes it an important target in infectious diseases, especially the treatment of multidrug-resistant organisms.
Glycopeptides (vancomycin, teicoplanin) bind to the D-Ala-D-Ala terminus, inhibiting transpeptidation and transglycosylation by physically blocking enzymes responsible for cross-linking peptidoglycan chains, thus preventing bacterial cell wall formation and causing cell death. D-cycloserine inhibits D-Ala-D-Ala ligase needed for terminus formation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-alanine terminus of bacterial peptidoglycan precursor (None commonly used.).